New product release announcement – 04/08/2014
Ariti SA is ready to launch the new pharmaceutical product ARITAXEL® 20mg/0,5ml and ARITAXEL® 80 mg/2ml (Active substance: Docetaxel) for the treatment of several types of cancer.

Ariti SA is ready to launch the new pharmaceutical product ARITAXEL® 20mg/0,5ml and ARITAXEL® 80 mg/2ml (Active substance: Docetaxel) for the treatment of several types of cancer.
Ariti SA participated in the 1st Symposium in Clinical Oncology which took place at Rhodes island in 31 March 2013 ( Rodos Park hotel). The Symposium was organized by the Medical Association of Rhodes.
Ariti SA is ready to launch the new pharmaceutical product Gemlag® (Active substance: Gemcitabine Hydrochloride ) for the treatment of several types of cancer.
Ariti SA is supporting the charity concert of the Scientific Oranization E.M.E.I.S which will take place on Friday 7th of June 2013, at Lycabetus thiatre , Athens.